Timezone: US/Eastern

Last Price Update:
2019-09-05 06:10:54



Ex-Dividend Calendar



Common Stock Sectors



Collections



West Pharmaceutical Services Inc.

Symbol: WST     Sector: Healthcare     Industry: Medical Instruments & Equipment

Dividend Yield
0.48%
Current Price
$124.22
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-10 19:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
443,500,000
443,500,000
296,700,000
146,800,000
76,100,000
70,700,000
55,400,000
-
-
195,500,000
1,372,900,000
-
-
265,500,000
-
-
47,600,000
 
9,800,000

Financials 2018

Update: 2019-06-10 19:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
422,500,000
422,500,000
289,300,000
133,200,000
71,500,000
61,700,000
52,000,000
894,400,000
1,978,900,000
582,600,000
1,396,300,000
337,400,000
100,000
337,400,000
196,100,000
36,400,000
73,200,000
 
9,800,000

Q 3

2018-09-30
431,700,000
431,700,000
296,100,000
135,600,000
72,300,000
63,300,000
55,200,000
850,100,000
1,946,100,000
594,300,000
1,351,800,000
297,300,000
-
297,300,000
-
72,000,000
88,400,000
 
10,100,000

Q 2

2018-06-30
447,500,000
447,500,000
305,300,000
142,200,000
79,400,000
62,800,000
56,100,000
766,900,000
1,873,700,000
591,800,000
1,281,900,000
225,500,000
-
225,500,000
-
39,300,000
82,000,000
 
10,800,000

Q 1

2018-03-31
415,700,000
415,700,000
281,300,000
134,400,000
77,400,000
57,000,000
43,600,000
743,500,000
1,869,600,000
564,300,000
1,305,300,000
199,800,000
-
199,800,000
-
-40,600,000
45,000,000
 
9,600,000

Financials 2017

Update: 2019-06-10 19:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
415,600,000
415,600,000
287,300,000
128,300,000
-174,900,000
303,200,000
743,500,000
1,862,800,000
582,900,000
1,279,900,000
235,900,000
-
235,900,000
-
-34,400,000
81,500,000
 
9,700,000